Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Savitz Ryan sold 8,224 Dianthus Therapeutics, Inc. shares (Form 4)
Traded Apr 9, 2026 · Filed Apr 10, 2026
On Apr 9, 2026, Savitz Ryan (EVP, CFO & CBO) sold 8,224 Dianthus Therapeutics, Inc. shares at US$89.84 for US$739K under a trading plan, leaving 0 shares. Filed Apr 10, 2026 (Form 4).
- Sold
- 8,224 shares
- Price
- US$89.84
- Value
- US$739K
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, CFO & CBO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 9, 2026 | Common Stock | Option exercise | 8,224 | US$17.88 | 8,224 | Direct |
| Apr 9, 2026 | Common Stock | Sale | 8,224 | US$89.84 | 0 | Direct |
Source
Related
- Dianthus Therapeutics, Inc.
- Savitz Ryan
- Dianthus Therapeutics, Inc. shareholders
- Form 4 · Savitz Ryan · Jul 13, 2026
- Form 4 · Savitz Ryan · Apr 1, 2026
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026